France Exosomes Market Size & Outlook, 2026-2033
- Biotechnology
- RNA analysis
- Exosomes Market Outlook
- RNA analysis
Global Market
Related Markets
Ask Prism AI anything about the exosomes market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
France exosomes market highlights
- The France exosomes market generated a revenue of USD 7.4 million in 2024 and is expected to reach USD 32.5 million by 2030.
- The France market is expected to grow at a CAGR of 28.3% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2024.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2024 | USD 7.4 million |
| Market revenue in 2030 | USD 32.5 million |
| Growth rate | 28.3% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, France accounted for 4.2% of the global exosomes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany exosomes market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 42.3 million by 2030.
Focus of biotechnology investors in research for exploring the potential applications of exosomes has increased in France over the years. According to a statistical analysis published by BioMed Research International in 2019, France was among the top five key contributing countries engaged in exosome research.
In addition, University de Bordeaux (France) carried out a research in 2017 that highlighted the significance of exosomes in the intercellular communication in patients suffering from neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, inflammation, and multiple sclerosis.
No credit card required*
Publish Date: May 05, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | www.miltenyibiotec.com |
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | roosterbio.com |
France Exosomes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 58.11% in 2024.
Horizon Databook has segmented the France exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Focus of biotechnology investors in research for exploring the potential applications of exosomes has increased in France over the years. According to a statistical analysis published by BioMed Research International in 2019, France was among the top five key contributing countries engaged in exosome research.
In addition, University de Bordeaux (France) carried out a research in 2017 that highlighted the significance of exosomes in the intercellular communication in patients suffering from neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, inflammation, and multiple sclerosis.
- France Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Isolation Methods
- Downstream Analysis
- France Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Kits & Reagents
- Instruments
- Services
- France Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & diagnostics centers
- Pharmaceutical & biotechnology companies
- Academic & research institutes
- France Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurodegenerative diseases
- Cardiovascular diseases
- Others
- Cancer
- Infectious diseases
Reasons to subscribe to Exosomes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Exosomes Market Outlook databook
- Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
France Exosomes Market, 2021-2033 (US$M)
France exosomes market statistics, by workflow, 2021-2033 (US$M)
